Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.
-
Research
- Experts
In The News
View All
WFYI features Regenstrief Institute Study
WFYI featured a study by Regenstrief Institute and the IU...
Influence
View All
Supply, demand, and a growing US kidney transplant waiting list
Published in JAMA Network Open. Here is a link to...
- Opportunities
- Experts
Influence
February 13, 2020
Regenstrief researchers leading core of national research incubator
Related News
Supply, demand, and a growing US kidney transplant waiting list
Published in JAMA Network Open. Here is a link to the article. Regenstrief Institute author: Rachel Patzer, PhD, MPH
Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy
Published in Journal of the American College of Cardiology (JACC) CardioOncology. Here is a link to the article. Regenstrief
Study reveals gaps in flu treatment for high-risk adults
INDIANAPOLIS – A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent
Regenstrief Institute researcher departs after more than two decades of service
After more than two decades of impactful work in Indiana, Michael Weiner, M.D., MPH, is departing Regenstrief Institute, Indiana